Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Sanjeev is currently the Country President for AstraZeneca Malaysia
To focus on providing safer burn treatments for women and armed forces
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
Silodosin capsules treat signs and symptoms of an enlarged prostate gland
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
Subscribe To Our Newsletter & Stay Updated
